The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams

OBJECTIVES: MRI is an integral part of breast cancer screening in high-risk patients. We investigated whether the application of the Kaiser score, a clinical decision-support tool, may be used to exclude malignancy in contrast-enhancing lesions classified as BI-RADS 4 on breast MRI screening exams....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Radiol
Egile Nagusiak: Milos, Ruxandra Iulia, Pipan, Francesca, Kalovidouri, Anastasia, Clauser, Paola, Kapetas, Panagiotis, Bernathova, Maria, Helbich, Thomas H., Baltzer, Pascal A. T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2020
Gaiak:
Breast
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553895/
https://ncbi.nlm.nih.gov/pubmed/32504098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-020-06945-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak